Long-term testosterone undecanoate treatment in the elderly testosterone deficient male: An observational cohort study.

Julie AbildgaardJørgen Holm PetersenAnne Kirstine BangLise AksglaedePeter ChristiansenAnders JuulNiels Jørgensen

Published in: Andrology (2021)

An increased number of adjustments of TU dose are necessary in elderly patients in order to reach treatment targets. TU treatment in elderly testosterone-deficient patients is not associated with an increased risk of polycythemia compared to younger patients if age-adjusted treatment targets are reached.

Keyphrases

end stage renal disease
replacement therapy
newly diagnosed
ejection fraction
prognostic factors
combination therapy
patient reported outcomes
patient reported